The effect of low doses of diethyldithiocarbamate (DEDC) on hepatic cytochrome P450-dependent enzyme activity and 1,3-dichloro-2-propanol (DCP) hepatotoxicity in the rat have been investigated. DEDC at a dose of 5 mg/kg selectively inhibited enzyme markers for CYP2E1 activity, and provided substantial protection against DCP hepato toxicity. At a higher dose (25 mg/kg), DEDC also inhibited an enzyme marker for CYP1A2 activity and provided complete protection against DCP hepatotoxicity. It is concluded: (a) that DEDC at a dose of 5 mg/kg is a selective CYP2E1 inhibitor in the rat in vivo; and (b) that DCP hepatotoxicity is mediated principally by CYP2E1, with a possible contribution from CYP1A2.
Haratake J. et al. Submassive hepatic necrosis induced by dichloropropanols. Liver1993; 13: 123-129.
2.
Shiozaki T. et al. Fulminant hepatitis following exposure to dichlorohydrin - report of two cases. Human & Experimental Toxicology1994; 13: 267-270.
3.
Hammond AH, Garle MJ, Fry JRToxicity of dichloropropanols in rat hepatocyte cultures. Environmental Toxicology and Pharmacology1996; 1: 39-43.
4.
Morgan ET, Koop DR, Coon MJCatalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Journal of Biological Chemistry1982; 257: 13951-13957.
5.
Newton DJ, Wang RW, Lu Ayh.Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition1995; 23: 154-158.
6.
Miller GE, Zemaitis MA, Greene FEMechanisms of diethyldithiocarbamate-induced loss of cytochrome P-450 from rat liver. Biochemical Pharmacology1983 ; 32: 2433-2442.
7.
Lauriault VV , Khan S., O'Brien PJHepatocyte cytotoxicity induced by various hepatotoxins mediated by cytochrome P-450IIE1: protection with diethyldithiocarbamate administration. Chemico-Biological Interactions1992; 81: 271-289.
8.
Hammond AH, Fry JRInvolvement of cytochrome P4502E1 in the toxicity of dichloropropanol to rat hepatocyte cultures. Toxicology; in press.
9.
Fentem JH, Fry JRComparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities. Xenobiotica1991; 21: 895-904.
10.
Schenkman JB , Remmer H., Estabrook RWSpectral studies of drug interactions with hepatic microsomal cytochrome P-450. Molecular Pharmacology1967; 3: 113-123.
11.
Omura T., Sato R.The carbon monoxide binding pigment of liver microsomes. I Evidence for its hemoprotein nature. Journal of Biological Chemistry1964; 239: 2379-2385.
12.
Fernyhough L. et al. Comparison of in vivo and in vitro rat hepatic toxicity of coumarin and methyl analogues, and application of quantitative morphometry to toxicity in vivo. Toxicology1994; 88: 113-125.
13.
Burke MD et al. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochemical Pharmacology1994; 48: 923-936.
14.
Zhang X-J., Thomas PEErythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats. Drug Metabolism and Disposition1996; 24: 23-27.
15.
Koop DR, Laethem CL, Tierney DJThe utility of p-nitrophenol hydroxylation in P450IIE1 analysis. Drug Metabolism Reviews1989; 20: 541- 551.
16.
Lucas D. et al. Ethanol-inducible cytochrome P-450: assessment of substrates' specific chemical probes in rat liver microsomes. Alcoholism: Clinical and Experimental Research1990; 14: 590-594.
17.
Masuda Y., Nakayama N.Protective effect of diethyldithiocarbamate and carbon disulfide against liver injury induced by various hepatotoxic agents. Biochemical Pharmacology1982; 31: 2713-2725.
18.
Ishiyama H. et al. Hepatotoxicity of diethyldithiocarbamate in rats. Pharmacology and Toxicology1990; 67: 426-430.
19.
Raucy JL, Kraner JC, Lasker JMBioactivation of halogenated hydrocarbons by cytochrome P4502E1. Critical Reviews in Toxicology1993; 23: 1-20.
20.
Lutz LM, Glende EA, Recknagel ROProtection by diethyldithiocarbamate against carbon tetrachloride lethality in rats and against carbon tetrachloride-induced lipid peroxidation in vitro . Biochemical Pharmacology1973; 22: 1729-1734.
21.
Liu J. et al. Antioxidant activity of diethyldithiocarbamate. Free Radical Research1996; 24: 461-472.
22.
Frank N., Christmann A., Frei E.Comparative studies on the pharmacokinetics of hydrophilic prolinedithiocarbamate, sarcosinedithiocarbamate and the less hydrophilic diethyldithiocarbamate. Toxicology1995; 95: 113-122.
